Tuesday, 6 September 2016

Rituxan




In the US, Rituxan (rituximab systemic) is a member of the following drug classes: antirheumatics, CD20 monoclonal antibodies and is used to treat Bullous Pemphigoid, Chronic Lymphocytic Leukemia, Evan's Syndrome, Follicular Lymphoma, Idiopathic Thrombocytopenic Purpura, Microscopic polyangiitis, Non-Hodgkin's Lymphoma, Pemphigoid, Pemphigus, Rheumatoid Arthritis and Wegener's Granulomatosus.

US matches:

  • Rituxan

Ingredient matches for Rituxan



Rituximab

Rituximab is reported as an ingredient of Rituxan in the following countries:


  • Canada

  • Japan

  • United States

International Drug Name Search

No comments:

Post a Comment